Chronic inducible urticaria
MONDO:0956969A chronic urticaria that is characterized by a history of a consistent stimulus that initiates lesions, which are typically short-lived and fleeting, lasting a few minutes up to 2 hours.
9 clinical trials for this condition and its sub-types, 8 tagged with Chronic inducible urticaria itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New shot may stop hives from cold and scratching
Disease control Recruiting nowThis study tests an investigational drug called barzolvolimab in 240 adults who get hives from cold temperatures or from scratching their skin, and whose symptoms are not controlled by standard allergy pills. Participants receive either the drug or a placebo injection, and doctor…
Phase 3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug aims to calm stubborn hives triggered by cold or scratching
Symptom relief Recruiting nowThis early-stage study tests a single dose of an experimental drug called GTX-B001 in healthy people and those with chronic inducible urticaria—a condition where cold or scratching causes painful hives. The main goal is to check safety and how the body handles the drug. About 72 …
Phase 1 • Sponsor: Granular Therapeutics Limited • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New pill for chronic hives enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage trial tests the safety of an experimental oral drug called EDP-978 in 98 healthy adults. Researchers will give single and multiple doses to see how the body handles it and whether it causes side effects. The drug is being developed for chronic hives, but this stu…
Phase 1 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC